Search Results 171-180 of 17252 for Capillary

1. Emphysema Clinical Trials - Mayo Clinic Research

   This is a multicenter, open-label trial to evaluate the safety and efficacy of inhaled treprostinil in subjects with pre-capillary pulmonary hypertension ...

2. Stroke and Vascular Disease Lab: Owen A. Ross - Research Projects

   Cerebral cavernous malformation causes vascular capillary abnormalities that easily rupture. Microtubule-associated protein krev interaction trapped 1 ...

3. SYMPHONY: A Study of Macitentan in Pulmonary Arterial Hypertension to Validate the PAH-SYMPACT - Mayo Clinic

   Pulmonary capillary wedge pressure (PCWP) or left ventricular end diastolic pressure (LVEDP) ≤ 15 mmHg. 6-minute walk distance (6MWD) ≥ 150 m at Screening ...

4. Henoch-Schonlein purpura - Symptoms & causes - Mayo Clinic

   Learn about the symptoms, causes and treatment of this illness, also called IgA vasculitis, that causes a rash on the legs.

5. A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS). - Mayo Clinic

   - Diagnosis of pulmonary veno-occlusive disease or pulmonary capillary hemangiomatosis - Initiation or discontinuation of an exercise program for ...

6. A Study of Inorganic Nitrite to Amplify the Benefits and Tolerability of Exercise Training in Heart Failure that has Preserved Ejection Fraction - Mayo Clinic

   Catheterization documented elevated filling pressures at rest (Pulmonary Capillary Wedge Pressure (PCWP) = ≥ 15 or Left Ventricular End-Diastolic Pressure ( ...

7. Publications - Sandra M. Herrmann, M.D. - Mayo Clinic

   Successful Treatment of Pembrolizumab-Induced Severe Capillary Leak Syndrome and Lymphatic Capillary Dysfunction. Mayo Clin Proc Innov Qual Outcomes. 2021 ...

8. A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) - Mayo Clinic

   Documented history of capillary leak syndrome. Grade 2 or higher pleural or pericardial effusion within 4 weeks of randomization or earlier history of ...

9. Study of Levosimendan in Pulmonary Hypertension Patients with Heart Failure and Preserved Left Ventricular Ejection Fraction (PHHFpEF) - Mayo Clinic

   Pulmonary capillary wedge pressure (PCWP) ≥20 mmHg at rest or with legs up (at baseline right heart catheter/Lead-In); NYHA Class II or III d. LVEF ≥40 ...

10. Role of the Gut Microbiome in Pulmonary Hypertension - Mayo Clinic

    PAH as defined by the 2008 WHO Group I Classification (Dana Point), but excluding pulmonary capillary hemangiomatosis and pulmonary veno-occlusive disease.